Serum interleukin 6 and C-reactive protein levels correlate with resistance to IL-2 therapy and poor survival in melanoma patients.

por Tartour, E., Dorval, T., Mosseri, V., Deneux, L., Mathiot, C., Brailly, H., Montero, F., Joyeux, I., Pouillart, P., Fridman, W. H.
Publicado 1994

Summary report of the Standards, Options and Recommendations for the use of serum tumour markers in breast cancer: 2000

por Basuyau, J P, Blanc-Vincent, M P, Bidart, J M, Daver, A, Deneux, L, Eche, N, Gory-Delabaere, G, Pichon, M F, Riedinger, J M
Publicado 2003